Taille du marché européen des tests de diagnostic rapide (POCT), tendances, rapport sur la croissance en 2033

Europe Poct Market

Taille du marché en milliards USD

TCAC : 9.40 %

USD 16.43 Billion USD 33.65 Billion 2025 2033

Période de prévision	2026 –2033
Taille du marché (année de référence)	USD 16.43 Billion
Taille du marché (année de prévision)	USD 33.65 Billion
TCAC	9.40 %
Principaux acteurs du marché	Abbott Point of Care Inc. Sinocare Inc. F. Hoffmann-La Roche Ltd Danaher Corporation Hologic Inc.

Marché européen des tests au point de service (POCT), par type de produit (produits de surveillance du glucose, produits de dépistage des maladies infectieuses, produits de surveillance cardiométabolique, produits de test de grossesse et de fertilité, produits de test d'hématologie, produits de surveillance de la coagulation, produits de test de drogues d'abus (DOA), produits de test d'analyse d'urine, produits de test de cholestérol, produits de test de marqueurs tumoraux/cancer, produits de test d'occultation fécale, et autres), par plateforme (tests de flux latéral/tests d'immunochromatographie, immuno-essais, bandelettes réactives, diagnostics moléculaires, tests de chimie clinique, microfluidique, hématologie, autres), par application (glycémie, maladies infectieuses, surveillance des signes vitaux, surveillance cardiaque, coagulation, hématologie, surveillance non invasive de la SpO2, transfusion sanguine, surveillance non invasive de la PCO2, analyse du sang total, Autres), par mode de prescription (tests sur ordonnance et tests en vente libre), par utilisateur final (hôpitaux, soins à domicile, cliniques, laboratoires, centres de diagnostic, laboratoires de pathologie, centres de chirurgie ambulatoire, centres de soins pour personnes âgées, autres), par canal de distribution (appel d'offres direct, ventes au détail, ventes en ligne et autres) - Tendances et prévisions du secteur jusqu'en 2032

Analyse du marché européen des tests au point de service (POCT)

Le marché européen des tests au point de service (POCT) connaît une croissance significative grâce aux progrès des technologies médicales, à la demande croissante de diagnostics rapides et à l'augmentation des maladies chroniques. Le PoCT permet d'obtenir des résultats rapides sur place, améliorant ainsi les résultats des patients et réduisant les coûts de santé. Parmi les principaux moteurs figurent l'intérêt croissant pour la médecine personnalisée, le vieillissement de la population et la commodité des tests à domicile. De plus, les innovations en matière de santé mobile (mHealth) et d'appareils portables façonnent le marché. L'Amérique du Nord détient la plus grande part de marché, tandis que l'Asie-Pacifique devrait connaître la croissance la plus rapide grâce à l'amélioration des infrastructures et de la demande en soins de santé.

Taille du marché européen des tests au point de service (POCT)

La taille du marché européen des tests au point de service (POCT) était évaluée à 21,63 milliards USD en 2024 et devrait atteindre 10,65 milliards USD d'ici 2032, avec un TCAC de 9,3 % au cours de la période de prévision de 2025 à 2032. Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse des importations et des exportations, un aperçu de la capacité de production, une analyse de la consommation de production, une analyse des tendances des prix, un scénario de changement climatique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire.

Tendances du marché européen des tests au point de service (POCT)

« Adoption croissante des technologies de diagnostic avancées dans les tests au point de service (POCT) en Europe »

Le marché européen des tests de dépistage au point de service (POCT) connaît une croissance significative, portée par les progrès des technologies diagnostiques, la demande croissante de tests rapides et le besoin constant de solutions de santé accessibles. Parmi les principales tendances, on peut citer l'essor des systèmes de santé décentralisés, où les tests passent des laboratoires centralisés à des environnements centrés sur le patient, comme le domicile, les pharmacies et les cliniques. L'adoption croissante d'appareils de santé mobiles et de dispositifs portables permet un suivi en temps réel et des résultats diagnostiques immédiats. De plus, les innovations en matière de tests moléculaires et génétiques améliorent la précision et élargissent le champ d'application des POCT à un plus large éventail de pathologies, des maladies infectieuses aux maladies chroniques. Le soutien réglementaire et les politiques de remboursement favorables soutiennent encore l'expansion du marché. Par ailleurs, la pandémie de COVID-19 a accéléré l'utilisation des POCT pour la détection rapide des infections virales, consolidant ainsi leur rôle dans la gestion de la santé publique. Face à la demande croissante d'outils de diagnostic plus rapides et plus pratiques, le marché des POCT devrait poursuivre sa croissance, en mettant l'accent sur l'accessibilité financière, la convivialité et l'intégration aux plateformes de santé numériques.

Portée du rapport et segmentation du marché européen des tests au point de service (POCT)

Attributs	Analyse du marché européen des tests au point de service (POCT)
Segments couverts	Par type de produit : (produits de surveillance du glucose, produits de test des maladies infectieuses, produits de surveillance cardiométabolique, produits de test de grossesse et de fertilité, produits de test d'hématologie, produits de surveillance de la coagulation, produits de test de drogues d'abus (DOA), produits de test d'analyse d'urine, produits de test de cholestérol, produits de test de marqueurs tumoraux/cancer, produits de test d'occultation fécale et autres) Par plateforme : (dosages à flux latéral/tests d’immunochromatographie, immuno-essais, bandelettes réactives, analyses moléculaires, diagnostics, analyses de chimie clinique, microfluidique, hématologie, autres) Par application : glycémie, maladies infectieuses, surveillance des signes vitaux, surveillance cardiaque, coagulation, hématologie, surveillance non invasive de la SpO2, transfusion sanguine, surveillance non invasive de la PCO2, analyse du sang total, autres Par mode de prescription : tests sur ordonnance, tests en vente libre Par utilisateur final : hôpitaux, soins à domicile, cliniques, laboratoires, centres de diagnostic, laboratoires de pathologie, centres de chirurgie ambulatoire, centres de soins pour personnes âgées, autres Par canal de distribution : appel d'offres direct, vente au détail, vente en ligne et autres
Région couverte	Les pays couverts par le marché sont l'Allemagne, la France, le Royaume-Uni, l'Italie, l'Espagne, la Russie, les Pays-Bas, la Suisse, la Turquie, la Belgique, la Suède, le Danemark, la Finlande, la Norvège, la Pologne et le reste de l'Europe.
Principaux acteurs du marché	F. Hoffmann-La Roche Ltd (Suisse), Danaher Corporation (États-Unis), Siemens Healthineers AG (Allemagne), BD (Becton, Dickinson and Company) (États-Unis), Abbott (États-Unis), Pfizer Inc. (États-Unis), QuantuMDx Group Ltd. (Royaume-Uni), Thermo Fisher Scientific Inc. (États-Unis), Nova Biomedical (États-Unis), Trividia Health, Inc. (États-Unis), Sienco, Inc. (États-Unis), PTS Diagnostics (États-Unis), Abaxis (filiale de Zoetis) (États-Unis), Werfen (Espagne), Binx Health (États-Unis), BIOMÉRIEUX (France), QIAGEN (Allemagne), QuidelOrtho Corporation (États-Unis), Accubiotech Co., Ltd. (Chine), Sekisui Diagnostics (États-Unis), Trinity Biotech (Irlande), BD Veritor (BD) (États-Unis), Hologic, Inc. (États-Unis), Sysmex Corporation (Japon) et Meridian Bioscience (États-Unis)
Opportunités de marché	Utilisation croissante des tests POC dans les établissements de santé Augmentation de l'incidence de la toxicomanie
Ensembles d'informations de données à valeur ajoutée	Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse des importations et des exportations, un aperçu de la capacité de production, une analyse de la consommation de production, une analyse des tendances des prix, un scénario de changement climatique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire.

Définition du marché européen des tests au point de service (POCT)

Le marché européen des tests de diagnostic au point de service (POCT) désigne les tests diagnostiques effectués sur le lieu de soins ou à proximité, comme à domicile, en clinique, en pharmacie ou à l'hôpital, et fournissant des résultats rapides et précis. Les POCT comprennent des dispositifs permettant de tester diverses pathologies, des maladies infectieuses aux maladies chroniques comme le diabète et les maladies cardiaques. Ce marché est stimulé par les avancées technologiques, notamment les appareils portables, les solutions de santé mobiles et les objets connectés, permettant des diagnostics en temps réel. La demande croissante de soins de santé pratiques et économiques, notamment dans les environnements décentralisés, ainsi que des politiques réglementaires favorables, stimulent l'expansion du marché des POCT en Europe.

Dynamique du marché européen des tests au point de service (POCT)

Conducteurs

Utilisation croissante des tests POC dans les établissements de santé

L'utilisation croissante des tests au point d'intervention (POC) dans les établissements de santé révolutionne la façon dont les professionnels de santé diagnostiquent et prennent en charge les maladies. Face au besoin croissant de résultats diagnostiques rapides et précis, les professionnels de santé se tournent vers les tests au point d'intervention pour améliorer la prise en charge des patients. Cette évolution est particulièrement visible aux urgences, en consultation externe et dans les centres de diagnostic, où la rapidité de la prise de décision est cruciale. Les tests au point d'intervention permettent aux professionnels de santé d'obtenir des résultats immédiats au point d'intervention, éliminant ainsi l'attente des résultats de laboratoire et réduisant considérablement les délais de diagnostic et de traitement. De plus, les tests au point d'intervention sont très portables et conviviaux, ce qui les rend idéaux pour une utilisation dans divers environnements de soins, des cliniques rurales aux grands hôpitaux. La prévalence croissante des maladies chroniques et la demande croissante de solutions de soins de santé efficaces alimentent l'adoption des tests au point d'intervention, car ils permettent un meilleur suivi des maladies, notamment du diabète, des maladies cardiovasculaires et des maladies infectieuses. À mesure que les établissements de santé intègrent de plus en plus ces technologies à leurs flux de travail, la demande de tests au point d'intervention continue de croître, constituant un moteur essentiel de l'expansion du marché.

Par exemple,

En mars 2024, selon un article publié par le NCBI, la rapidité d'exécution du POCT améliore la prise de décision clinique, réduit le temps de gestion et optimise l'efficacité du triage, notamment aux urgences. Sa flexibilité s'étend aux contextes préhospitaliers, aux hôpitaux de campagne, ainsi qu'aux catastrophes, aux rassemblements de masse ou aux zones surpeuplées. Cette adoption généralisée du POCT dans les établissements de santé accélère sa demande, agissant comme un moteur important pour le marché européen.
En novembre 2024, selon un article publié par OBJECTIVE Investment Banking & Valuation, l'adoption des tests au point d'intervention (POCT) a révolutionné les soins de santé en apportant le diagnostic directement au patient. Sa rapidité, sa commodité et son efficacité en font un outil précieux pour les urgences, les consultations externes et les interventions à distance. Face à la demande croissante de diagnostics rapides, l'intégration des POCT dans les pratiques cliniques stimule l'expansion du marché et constitue un catalyseur essentiel de la croissance du marché européen.
L'adoption croissante des tests au point d'intervention (POC) dans les établissements de santé transforme le diagnostic et la prise en charge des maladies. Face à la nécessité de résultats rapides et précis, les professionnels de santé utilisent les tests au point d'intervention pour améliorer la prise en charge des patients. Ceci est particulièrement important aux urgences, en consultation externe et dans les centres de diagnostic, où une prise de décision rapide est essentielle. Les tests au point d'intervention offrent des résultats immédiats, réduisant les délais d'attente pour les comptes rendus de laboratoire et accélérant le diagnostic et le traitement. Leur portabilité et leur simplicité d'utilisation les rendent adaptés à divers environnements de soins, des cliniques rurales aux grands hôpitaux. La prévalence croissante des maladies chroniques comme le diabète et les maladies cardiovasculaires, ainsi que la demande de solutions de soins de santé efficaces, stimulent encore davantage le recours aux tests au point d'intervention, favorisant une meilleure prise en charge des maladies et la croissance du marché.

Augmentation de l'incidence de la toxicomanie

L'augmentation de l'incidence de la toxicomanie dans le monde a contribué de manière significative à la croissance du marché européen des tests de dépistage au point de service (TPS). Face à l'augmentation du nombre de personnes touchées par des troubles liés à la consommation de substances, il existe un besoin urgent d'outils de diagnostic rapides et fiables, capables d'identifier rapidement les cas de toxicomanie et de suivre l'efficacité des traitements. Les TPS offrent l'avantage de fournir des résultats immédiats, indispensables à une intervention rapide, notamment en cas d'urgence ou lorsque les patients nécessitent des soins urgents. Cette méthode de dépistage permet aux professionnels de santé de détecter en temps réel des substances telles que l'alcool, les opioïdes et les drogues illicites, facilitant ainsi la prise de décision et l'élaboration de stratégies de traitement plus efficaces. De plus, face à la sensibilisation croissante aux problèmes de toxicomanie, la demande de solutions de dépistage accessibles et abordables dans divers établissements de santé, tels que les cliniques, les centres de traitement des addictions et les centres de réadaptation, ne cesse de croître. Face à la multiplication des initiatives gouvernementales et de santé publique pour lutter contre la toxicomanie, les TPS jouent un rôle essentiel dans la gestion de la crise, favorisant leur adoption généralisée et stimulant la croissance du marché.

Par exemple,

En janvier 2024, selon un article publié par le NCBI, les troubles liés à l'usage d'opioïdes (TUO) touchaient plus de 16 millions de personnes dans le monde, dont 2,1 millions aux États-Unis, entraînant plus de 120 000 décès chaque année en Europe. La prévalence de la consommation et de la dépendance aux opioïdes est élevée, jusqu'à 50 % des consommateurs d'opioïdes de longue durée répondant aux critères du TUO. L'incidence croissante des problèmes liés aux opioïdes renforce le besoin de solutions efficaces de dépistage des drogues, alimentant ainsi la croissance du marché européen des tests au point de service (POC).
En août 2023, selon un article publié par l'OMS, en 2019, environ 600 000 décès en Europe étaient liés à la consommation de drogues, dont environ 80 % aux opioïdes. Parmi ceux-ci, environ 125 000 étaient dus à une surdose d'opioïdes, tandis que les surdoses non mortelles sont nettement plus fréquentes. L'augmentation des surdoses d'opioïdes est attribuée à la disponibilité accrue d'opioïdes pour la gestion de la douleur chronique et à la présence d'opioïdes puissants sur le marché illicite. Aux États-Unis, le nombre de décès par surdose de drogues s'est élevé à 70 630 en 2019, les opioïdes synthétiques étant impliqués dans environ la moitié de ces cas. De 2013 à 2019, les taux de mortalité par opioïdes synthétiques aux États-Unis ont bondi de 1 040 %, avec un nouveau pic pendant la pandémie de COVID-19. Ces données soulignent « l’incidence croissante de la toxicomanie » en soulignant la prévalence et la gravité croissantes des surdoses liées aux opioïdes, ce qui stimule la demande de solutions efficaces de dépistage de drogues.
En juin 2020, selon un article publié par ARCHIVERS of pathology & Laboratory Medicine, l'épidémie d'opioïdes a créé une demande critique de tests de dépistage de drogues au point de service (POC), répondant à des besoins cliniques importants. Si les tests POC actuels sont limités en termes de sensibilité et de spécificité, des solutions innovantes comme la microfluidique et la spectrométrie de masse miniature émergent. Le développement futur de dispositifs POC quantitatifs et de tests en temps réel stimule encore davantage la demande, agissant comme un moteur clé de la croissance du marché dans le secteur de la toxicomanie.

L'augmentation de l'incidence de la toxicomanie en Europe a considérablement stimulé la croissance du marché des tests de dépistage au point d'intervention (TPPI). Face à la prévalence croissante des troubles liés à la consommation de substances, la demande d'outils de diagnostic rapides et précis pour détecter et surveiller la toxicomanie est en hausse. Le TPI offre des résultats immédiats, permettant des interventions rapides en cas d'urgence et des soins d'urgence. Il permet aux professionnels de santé d'identifier rapidement des substances comme l'alcool, les opioïdes et les drogues illicites, améliorant ainsi le traitement et la prise de décision. Grâce à une sensibilisation accrue et à des efforts de santé publique accrus pour lutter contre la toxicomanie, la demande de solutions de dépistage accessibles dans les cliniques et les centres de réadaptation ne cesse de croître, ce qui favorise l'adoption du TPI.

Adoption accrue de la télémédecine

La croissance rapide de la télémédecine a contribué de manière significative à l'essor des tests au point d'intervention (POCT), notamment dans le contexte des soins de santé à distance. Avec le développement des plateformes de télésanté, la demande d'outils de diagnostic permettant aux professionnels de santé de surveiller les patients à distance, de réaliser des évaluations et de fournir des résultats en temps réel augmente. Les solutions POCT jouent un rôle crucial dans cette transformation, car elles permettent aux professionnels de santé d'obtenir des résultats d'analyse précis et rapides, sans que les patients aient besoin de se déplacer en clinique ou à l'hôpital. Cette possibilité de réaliser des diagnostics à domicile ou dans des zones reculées améliore non seulement l'accès des patients aux soins, mais aussi l'efficacité des soins en réduisant les temps d'attente et la charge de travail des établissements de santé. L'intégration des POCT aux systèmes de télémédecine facilite une communication fluide entre les patients et les professionnels de santé, garantissant des interventions rapides. Avec la croissance continue de la télémédecine, la demande d'appareils POCT, essentiels pour fournir des diagnostics rapides et fiables dans un environnement de soins virtuels, devient un moteur clé de l'expansion du marché.

Par exemple,

En mars 2024, selon un article publié par la DPU, la télémédecine permet des services de santé à distance en connectant virtuellement les patients à des professionnels de santé, où qu'ils se trouvent. Dans le cadre des tests au point de service, les patients peuvent effectuer des autotests ou des tests administrés localement, dont les résultats sont transmis à des spécialistes pour analyse. Cela permet un accès rapide à des conseils médicaux spécialisés, notamment dans les zones mal desservies, ce qui accroît le besoin de solutions POCT et stimule la croissance du marché.
En février 2022, selon un article publié par Medical Device Network, le diagnostic au point d'intervention transforme les soins de santé à distance en offrant aux patients, notamment ceux atteints de maladies chroniques, un accès simplifié aux données diagnostiques. Cette évolution permet une surveillance continue et des interventions rapides, même dans les zones où les infrastructures de santé sont limitées. Avec l'adoption croissante de la télémédecine, la demande de solutions POCT efficaces et accessibles augmente, ce qui constitue un moteur important de l'expansion du marché européen.

La croissance rapide de la télémédecine a stimulé les tests au point d'intervention (POCT), notamment pour les soins de santé à distance. Avec le développement des plateformes de télésanté, le besoin d'outils de diagnostic permettant une surveillance à distance et des résultats en temps réel s'est accru. Le POCT permet aux professionnels de santé d'obtenir des résultats de tests précis sans consultation des patients, améliorant ainsi l'accès aux soins et réduisant les temps d'attente. L'intégration du POCT à la télémédecine simplifie la communication entre les patients et les professionnels de santé, garantissant des interventions rapides. Avec l'évolution de la télémédecine, la demande d'appareils POCT continue de stimuler la croissance du marché.

Opportunités

Sensibilisation et plaidoyer accrus en faveur des tests au point de service

La prise de conscience croissante de l'importance du diagnostic précoce, conjuguée à des campagnes de santé publique vigoureuses et au soutien des gouvernements, offre une opportunité de croissance significative pour le marché européen des tests de dépistage au point de service (PDS). L'accent mis par la société sur les soins de santé proactifs entraîne une demande croissante de solutions de dépistage accessibles et efficaces. Les campagnes de santé publique, menées par des organisations gouvernementales et non gouvernementales, jouent un rôle crucial pour sensibiliser les populations aux avantages d'un dépistage précoce et d'une intervention rapide. Ces initiatives sensibilisent non seulement à diverses pathologies, mais militent également en faveur d'une utilisation généralisée des tests au point de service pour améliorer les résultats des patients. De plus, le soutien gouvernemental, par le biais de financements et de politiques, facilite l'adoption des technologies de dépistage au point de service en établissant des cadres réglementaires favorables. Cela encourage la mise en œuvre de ces solutions dans divers contextes, tels que les cliniques, les hôpitaux et même les zones reculées ou mal desservies. La combinaison d'une sensibilisation accrue et d'un soutien gouvernemental stratégique crée un environnement favorable à l'expansion du marché, stimule l'innovation et élargit l'accès à des solutions de dépistage avancées pour répondre aux besoins croissants en matière de santé en Europe.

En décembre 2023, selon un article publié par la Greater London Authority, le gouvernement britannique a alloué 1,54 million de dollars à cette mission, axée sur le dépistage de 14 drogues différentes. La sensibilisation croissante et les initiatives gouvernementales proactives au Royaume-Uni ont conduit à la mise en place de tests de dépistage de drogues obligatoires et aléatoires pour les personnes libérées de prison, dans le but de réduire la criminalité. Cette initiative souligne l'engagement du pays à lutter contre la toxicomanie et son impact sur la criminalité, et s'inscrit dans une démarche plus large visant à améliorer la sécurité et le bien-être publics.
En juillet 2021, selon un article publié par le Commonwealth d'Australie et le ministère de la Santé et des Soins aux personnes âgées, le gouvernement australien a lancé la Stratégie nationale d'action contre la méthamphétamine (ICE), qui prévoyait des investissements importants pour améliorer le dépistage de la toxicomanie au point de service (POC). Cette initiative visait à freiner la consommation croissante de méthamphétamines, communément appelées « ice », en fournissant aux forces de l'ordre et aux professionnels de santé des outils de dépistage de drogues plus accessibles et plus précis. La stratégie visait également à étendre la disponibilité des tests au point de service (POC) dans les zones rurales et reculées, afin que les communautés de tout le pays puissent bénéficier de mesures rapides et efficaces de détection et d'intervention en matière de drogue.

Ainsi, la convergence d'une sensibilisation croissante, de campagnes proactives de santé publique et d'un soutien gouvernemental fort devrait stimuler une croissance substantielle du marché européen des tests de dépistage au point de service (PDS). Cet environnement dynamique accélère non seulement l'adoption des technologies de dépistage au point de service, mais favorise également le développement de solutions plus avancées, plus efficaces et plus accessibles. Face à l'évolution constante de ces facteurs, l'avenir des tests au point de service s'annonce prometteur, avec de nouvelles opportunités d'innovation, une plus grande portée commerciale et de meilleurs résultats en matière de santé à l'échelle mondiale.

Initiation stratégique et décision prise par les acteurs du marché

Les collaborations et partenariats stratégiques entre des entreprises leaders et des instituts de recherche stimulent le développement de technologies avancées de tests au point d'intervention (POCT) et élargissent leur portée commerciale. Ces collaborations permettent aux entreprises d'améliorer leur offre de produits, leur précision et leur clientèle. Les fusions et acquisitions renforcent encore le marché en intégrant des technologies complémentaires et en ouvrant l'accès à de nouveaux marchés. L'élargissement continu des portefeuilles de produits et l'introduction de solutions innovantes répondent aux besoins changeants de secteurs tels que la santé, l'éducation et le monde du travail. Ces efforts stratégiques contribuent collectivement à la croissance du marché des tests au point d'intervention, rendant les tests plus accessibles, plus précis et plus efficaces en Europe.

Par exemple,

En février 2021, selon un article publié par Thermo Fisher Scientific Inc., Thermo Fisher Scientific a acquis Mesa Biotech, une entreprise spécialisée dans les tests de diagnostic moléculaire au point de service (PDS). Si Mesa Biotech se concentrait principalement sur le dépistage des maladies infectieuses, cette acquisition a permis à Thermo Fisher de disposer de capacités supplémentaires en matière de tests rapides au point de service (PDS), ce qui lui a permis d'étendre ses activités au dépistage de la toxicomanie. Cette acquisition s'inscrit dans la stratégie globale de Thermo Fisher visant à enrichir son offre de tests au point de service (PDS) dans divers domaines diagnostiques.

En mai 2024, selon un article publié par ResearchGate, la demande croissante de diagnostics rapides, précis et accessibles représente une opportunité majeure pour le marché européen des tests au point de service (POCT). Alors que les systèmes de santé recherchent des alternatives plus efficaces aux tests de laboratoire traditionnels, les POCT offrent le potentiel d'améliorer la prise en charge des patients en permettant des résultats rapides, en réduisant les temps d'attente et en offrant un confort d'utilisation optimal, notamment dans les zones reculées ou à ressources limitées. De plus, l'intégration de technologies intelligentes et les avancées en matière de sensibilité des appareils peuvent stimuler l'innovation, améliorer la précision des tests et élargir le champ des pathologies diagnostiquées. L'ensemble de ces facteurs crée un environnement dynamique pour la croissance du marché et le développement de solutions POCT plus avancées et plus rentables.

En août 2022, selon l'article publié dans Healthcare Transformers, les POCT représentent une opportunité majeure pour les soins de santé en Europe, en améliorant l'accessibilité, notamment dans les zones mal desservies. Face à la demande croissante de diagnostics rapides et économiques, les unités mobiles et les solutions de proximité offrent des soins efficaces. Le potentiel des POCT à réduire les coûts de santé, à améliorer la détection précoce des maladies et à alléger la charge hospitalière stimule l'expansion du marché et l'innovation.

En conclusion, les décisions et initiatives stratégiques des acteurs clés sont cruciales pour stimuler la croissance du secteur des tests au point de service. En investissant dans des collaborations, des fusions et des extensions de portefeuille, les entreprises bénéficieront de progrès technologiques accrus et d'une disponibilité accrue des produits. Ces efforts répondront à la demande croissante de diagnostics rapides et précis, améliorant ainsi les résultats des soins de santé et favorisant une prise en charge plus efficace des patients dans divers secteurs.

Élargissement de la gamme de produits pour les tests au point de service

La diversité croissante des options de produits pour les tests de dépistage de drogues au point de service (POC) représente une opportunité de développement significative. Face à la demande croissante de tests rapides, précis et pratiques, les fabricants élargissent leur offre en incluant des bandelettes de test monodrogue, des cassettes multidrogues, des cartes de test et des godets. Cette gamme diversifiée de produits répond à différents besoins de dépistage, du simple dépistage à domicile aux évaluations multidrogues plus détaillées en milieu clinique et professionnel. En diversifiant leurs gammes de produits, les entreprises peuvent répondre à un plus large éventail de besoins des utilisateurs, améliorer l'accessibilité et gérer différents niveaux de complexité et de sensibilité de détection des drogues. Cette tendance répond non seulement à la demande croissante de solutions de dépistage de drogues efficaces, mais favorise également l'innovation et la concurrence, conduisant à des avancées technologiques et à une amélioration de la précision et de la fiabilité des tests.

Par exemple-

En janvier 2025, selon une étude publiée par ScienceDirect, l'article aborde les avancées en matière de tests au point d'intervention (POCT), en se concentrant sur les dosages à flux latéral et microfluidiques en une étape pour les tests à domicile. Les principaux axes d'intervention comprennent l'amplification du signal, la conception des dosages et la préparation des échantillons, visant à réduire l'intervention de l'utilisateur. L'accent est mis sur les défis de la commercialisation et sur la garantie de solutions diagnostiques rentables, fiables et accessibles.
Selon une étude publiée par Healgen en décembre 2023, l'entreprise propose une gamme diversifiée de produits, notamment des bandelettes, des cassettes et des cartes de test monodrogue, ainsi que des cassettes, des cartes de test multidrogue et des coupelles. Cette vaste gamme de produits répond à divers besoins et contextes de dépistage, des simples tests à domicile aux dépistages multidrogues plus complets.

L'expansion des types de produits sur le marché européen des tests au point de service (POC) devrait stimuler une croissance et une innovation significatives. À mesure que le marché évolue pour répondre aux divers besoins des utilisateurs et intégrer les avancées technologiques, un éventail plus large de solutions de test améliorera l'efficacité et la précision du diagnostic. Cette diversité accrue de produits (241 Europe Point-of-Care Testing Market - Industry Trends and Forecast to 2032) devrait stimuler la pénétration du marché, améliorer l'accessibilité et soutenir des programmes de tests plus complets, offrant ainsi une opportunité majeure d'expansion du marché.

Retenue/Défi

Sensibilisation et acceptation limitées

Le manque de sensibilisation et d'acceptation des tests au point de service (POC) peut freiner considérablement leur croissance et leur adoption généralisée. La lenteur de leur adoption par les professionnels de santé, les patients et les organismes payeurs complique la stimulation de la demande et des ventes de dispositifs au point de service. Une sensibilisation insuffisante peut entraîner une utilisation limitée dans les établissements de santé où ces tests sont les plus nécessaires, réduisant ainsi leur impact sur les soins et les résultats des patients. Un autre obstacle est l'absence de remboursement, car une acceptation limitée peut entraîner une réduction ou un refus des demandes de remboursement, ce qui rend plus difficile l'accès à ces technologies pour les professionnels de santé. De plus, l'absence de formation et d'éducation adéquates parmi les professionnels de santé peut compromettre l'utilisation et l'interprétation correctes des résultats des tests au point de service, conduisant à des diagnostics erronés.

Par exemple,

En décembre 2024, un article publié dans ScienceDirect aborde les défis et les facteurs favorisant l'adoption du dépistage au point de service (DPS) pour les infections des voies respiratoires (IVR) en soins primaires, notamment en Australie. Malgré les progrès technologiques, l'adoption du DPS reste faible en raison de facteurs tels que la disponibilité des ressources, la formation, le contrôle qualité et les attentes des patients. Cependant, le DPS peut réduire considérablement la surconsommation d'antimicrobiens en fournissant des diagnostics rapides et fondés sur des données probantes. Faciliter son déploiement à plus grande échelle en soins primaires est crucial pour améliorer la gestion des antimicrobiens et les résultats pour les patients. L'étude souligne l'importance de lever les principaux obstacles et d'élaborer des stratégies pour promouvoir l'adoption généralisée du DPS dans la prise en charge des IVR.
En juin 2024, selon un article publié dans ResearchGate, les tests au point de service (POCT) offrent des avantages tels que la rapidité, la commodité et des économies, mais posent également des défis tels qu'une précision moindre, des problèmes de contrôle qualité, une dépendance à l'opérateur et des préoccupations réglementaires. Alors que les POCT évoluent vers des modèles décentralisés et de vente directe au consommateur, une gouvernance rigoureuse et une évaluation de la qualité sont nécessaires pour garantir une prise de décision clinique fiable.

Pour relever ces défis, les fabricants devraient investir dans des programmes de formation ciblés destinés aux professionnels de santé et aux patients, en mettant l'accent sur les avantages et la bonne utilisation des tests POC. Ces efforts contribueront à accroître la sensibilisation, à améliorer l'adoption et à renforcer l'efficacité globale des tests POC dans les établissements de santé, et, in fine, à améliorer les résultats pour les patients.

L'impact des coûts de maintenance élevés menace la durabilité des tests au point de service (POCT) dans les environnements à faibles ressources

Le coût élevé de la maintenance constitue un défi majeur sur le marché européen des tests au point de service (POCT). L'étalonnage, l'entretien et la maintenance réguliers des appareils POCT sont essentiels pour garantir leur précision, leur fiabilité et leurs performances continues. Cependant, ces activités peuvent engendrer des coûts importants, notamment dans les établissements de santé à faibles ressources et aux budgets limités. De nombreux appareils POCT nécessitent une assistance technique périodique, incluant le remplacement des composants usés, les mises à jour logicielles et la conformité aux normes réglementaires, autant d'éléments qui contribuent aux dépenses opérationnelles globales. Pour les prestataires de soins des régions sous-financées, allouer des ressources à cette maintenance est souvent difficile, ce qui peut entraîner des temps d'arrêt prolongés, des risques opérationnels accrus et une précision diagnostique compromise. De plus, la complexité de certains appareils POCT nécessite l'intervention de techniciens spécialisés pour un entretien adéquat, ce qui augmente encore les coûts de maintenance. Ce problème est aggravé par le manque de formation du personnel local pour effectuer les tâches d'entretien de base, obligeant les établissements à recourir à un soutien externe coûteux. Par conséquent, de nombreux prestataires de soins peuvent retarder ou renoncer à la maintenance essentielle, réduisant ainsi l'efficacité globale et la durée de vie des équipements.

Par exemple,

En septembre 2020, selon un article publié dans la National Library of Medicine, le coût élevé des tests de dépistage au point de service (TPS) représente un défi majeur pour le marché européen. Les investissements initiaux en équipement, la maintenance continue et la formation des opérateurs peuvent être prohibitifs, surtout dans les contextes à faibles ressources. Cela limite leur adoption généralisée et nuit à leur rentabilité, malgré le potentiel des TPS pour améliorer les résultats des soins de santé.
En mai 2023, selon un article publié par la Bibliothèque nationale de médecine, le Centre national d'information sur les biotechnologies (NCBI) souligne que les dispositifs de diagnostic au point de service (POCT), bien que bénéfiques pour un diagnostic rapide, sont souvent confrontés à des coûts de maintenance élevés. L'étalonnage et l'entretien réguliers peuvent grever les ressources de santé, en particulier dans les milieux à faibles ressources, limitant ainsi l'utilisation durable de ces technologies.

Portée du marché européen des tests au point de service (POCT)

Le marché européen des tests au point de service (POCT) est segmenté en six segments distincts, selon le type de produit, le mode de prescription, l'application, la plateforme, l'utilisateur final et le canal de distribution. La croissance de ces segments vous permettra d'analyser les segments à faible croissance des secteurs et de fournir aux utilisateurs une vue d'ensemble et des informations précieuses sur le marché, facilitant ainsi la prise de décisions stratégiques pour identifier les applications clés.

Type de produit

Produits de surveillance du glucose
- Bandes
- Compteurs
- Lancettes et autopiqueurs
Produits de test des maladies infectieuses
- COVID-19 [feminine
- Produits de dépistage du VIH
  - Réactifs de test
  - Équipement d'essai
- Produits de test des infections respiratoires
- Dépistage des maladies sexuellement transmissibles (MST)
  - Systèmes basés sur Naat
  - Systèmes non basés sur Naat
- Produits de dépistage de l'hépatite C
  - Tests d'anticorps anti-VHC
  - Tests de charge virale du VHC
- Produits de dépistage de la grippe
  - Test de diagnostic traditionnel
    - Test de diagnostic rapide de la grippe (Ridt)
    - Test d'anticorps fluorescent direct (Dfat)
    - Culture virale
    - Dosage sérologique
- Test de diagnostic moléculaire
  - Rt-Pcr
  - Dosage par amplification isotherme à médiation par boucle (Lamp)
  - Test d'amplification basé sur la séquence d'acide nucléique (Nasbat)
  - Dosage basé sur l'amplification simple (Samba)
- Tests d'infections associées aux soins de santé (Hai)
- Produits de dépistage des maladies tropicales
- Autres produits de dépistage des maladies infectieuses
Produits de surveillance cardiométabolique
- Produits de test des marqueurs cardiaques
  - Hstnl
  - BNP
  - D-Dimère
  - Ck-Mb
  - Myoglobine
Produits de test des gaz sanguins et des électrolytes
- Consommables pour les tests de gaz sanguins et d'électrolytes
  - Cartouches
  - Réactifs
- Instruments de test des gaz et électrolytes sanguins
  - Portable
    - Analyseurs combinés
    - Analyseurs de gaz du sang
    - Analyseurs d'électrolytes
  - Paillasse
    - Analyseurs combinés
    - Analyseurs de gaz du sang
    - Analyseurs d'électrolytes
Produits de test Hba1c
- Instruments de test Hba1c
- Consommables pour le test Hba1c
Analyseur Poc
Appareil ECG
- Appareils ECG au repos
- Appareils d'ECG d'effort
- Moniteurs Holter
Produits de test de grossesse et de fertilité
- Produits de test de grossesse
  - Bandes/Bâtonnets et cartes
  - Appareils Mid Stream
  - Cassettes
  - Appareils numériques
  - Dispositifs indicateurs de ligne
- Produits de test de fertilité
  - Test urinaire de l'hormone lutéinisante (Lh)
  - Test Fsh
  - Autres
Produits de tests hématologiques
Produits de surveillance de la coagulation
- Dispositifs de surveillance de l'anticoagulation
  - Dispositifs de test du temps de prothrombine/rapport international normalisé (Pt-Inr)
  - Temps de coagulation activé (Act)
  - Temps de thromboplastine partielle activée (RDV)
- Dispositifs de surveillance de la fonction plaquettaire
- Dispositifs de surveillance de la coagulation viscoélastique
  - Thromboélastométrie rotationnelle (Rotem)
  - Thromboélastographie (Teg)
Produits de dépistage de drogues (DOA)
- Analyseurs Doa
  - Immunoessais
  - Dispositifs chromatographiques
  - Analyseurs d'haleine
- Dispositifs de test rapide
  - Dispositifs de test d'urine
  - Dispositifs de test de fluide oral
- Autres
Produits de test d'analyse d'urine
- Autotest par bandelette urinaire Poc
- Bandelette de test d'urine Poc Test professionnel
Produits de test du cholestérol
- Kits de test
- Instruments
  - Analyseurs de table
  - Analyseurs portables
Produits de test de marqueurs tumoraux/cancer
Produits de test occulte fécal
- Test de selles au gaïac Fob
- Test immuno-Fob à flux latéral
- Test d'agglutination Immuno-Fob
- Test Elisa Immuno-Fob
Autres

Plate-forme

Essais de flux latéral/Tests d'immunochromatographie
Immunoessais
Jauges
Diagnostic moléculaire
Dosages de chimie clinique
Microfluidique
Hématologie
Autres

Application

Glycémie
Maladies infectieuses
- Test Covid-19
- Dépistage du VIH
- Dépistage de l'hépatite C
- Test de grippe
- Dépistage de la tuberculose
- Autres
Surveillance des signes vitaux
Surveillance cardiaque
Coagulation
Hématologie
Surveillance non invasive de la SpO2
Transfusion sanguine
Surveillance non invasive de la Pco2
Analyse du sang total
Autres

Mode de prescription

Tests en vente libre
Tests sur ordonnance

Utilisateur final

Hôpitaux
- Privé
  - Niveau 1
  - Niveau 2
  - Niveau 3
- Publique
  - Niveau 1
  - Niveau 2
  - Niveau 3
Soins à domicile
Cliniques
Laboratoires
Centres de diagnostic
laboratoires de pathologie
Centres de chirurgie ambulatoire
Centres de soins pour personnes âgées
Autres

Canal de distribution

Appel d'offres direct
Ventes au détail
Ventes en ligne
Autres

Analyse régionale du marché européen des tests au point de service (POCT)

Le marché est analysé et des informations sur la taille et les tendances du marché sont fournies en fonction du pays, du type de produit, du mode de prescription, de l'application, de la plate-forme, de l'utilisateur final et du canal de distribution, comme indiqué ci-dessus.

Les pays couverts par le marché sont l'Allemagne, la France, le Royaume-Uni, l'Italie, l'Espagne, la Russie, les Pays-Bas, la Suisse, la Turquie, la Belgique, la Suède, le Danemark, la Finlande, la Norvège, la Pologne et le reste de l'Europe.

L'Allemagne devrait dominer le marché européen des tests au point de service (POCT) en raison de sa forte industrie des dispositifs médicaux, de ses dépenses de santé élevées et de ses capacités avancées de recherche et développement.

Le Royaume-Uni devrait être le marché à la croissance la plus rapide en Europe en raison des initiatives gouvernementales soutenant l’innovation diagnostique, de la demande croissante de tests à domicile et de la prévalence croissante des maladies infectieuses et chroniques.

La section pays du rapport présente également les facteurs d'impact sur les marchés individuels et les évolutions réglementaires nationales qui influencent les tendances actuelles et futures du marché. Des données telles que l'analyse des chaînes de valeur en aval et en amont, les tendances techniques, l'analyse des cinq forces de Porter et les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour chaque pays. De plus, la présence et la disponibilité des marques européennes et les difficultés rencontrées face à la concurrence forte ou faible des marques locales et nationales, l'impact des tarifs douaniers nationaux et les routes commerciales sont pris en compte lors de l'analyse prévisionnelle des données nationales.

Part de marché des tests au point de service (POCT) en Europe

Le paysage concurrentiel du marché fournit des détails par concurrent. Il comprend la présentation de l'entreprise, ses données financières, son chiffre d'affaires, son potentiel de marché, ses investissements en recherche et développement, ses nouvelles initiatives commerciales, sa présence en Europe, ses sites et installations de production, ses capacités de production, ses forces et faiblesses, le lancement de nouveaux produits, leur ampleur et leur portée, ainsi que la domination de ses applications. Les données ci-dessus ne concernent que les activités des entreprises par rapport à leur marché.

Les leaders du marché européen des tests au point de service (POCT) opérant sur le marché sont :

F. Hoffmann-La Roche SA (Suisse)
Danaher Corporation (États-Unis)
Siemens Healthineers AG (Allemagne)
BD (Becton, Dickinson and Company) (États-Unis)
Abbott (États-Unis) Pfizer Inc. (États-Unis)
QuantuMDx Group Ltd. (Royaume-Uni)
Thermo Fisher Scientific Inc. (États-Unis)
Nova Biomedical (États-Unis)
Trividia Health, Inc. (États-Unis)
Sienco, Inc. (États-Unis)
Diagnostics PTS (États-Unis)
Abaxis (une partie de Zoetis) (États-Unis)
Werfen (Espagne)
Binx Health (États-Unis)
BIOMÉRIEUX (France)
QIAGEN (Allemagne)
QuidelOrtho Corporation (États-Unis)
Accubiotech Co., Ltd. (Chine)
Sekisui Diagnostics (États-Unis)
Trinity Biotech (Irlande)
BD Veritor (BD) (États-Unis)
Hologic, Inc. (États-Unis)
Sysmex Corporation (Japon)
Meridian Bioscience (États-Unis)

Derniers développements sur le marché européen des tests au point de service (POCT)

En décembre 2023, Roche a acquis certains composants de la technologie innovante Point of Care de LumiraDx, enrichissant ainsi son portefeuille de diagnostics. Cette acquisition permet des tests plus rapides et plus abordables dans de nombreux domaines thérapeutiques. L'intégration de la plateforme LumiraDx améliorera l'accès des patients à des résultats diagnostiques rapides et précis dans les établissements de santé décentralisés en Europe.
En janvier 2025, Danaher Corporation a conclu un partenariat d'investissement avec Innovaccer Inc., une entreprise spécialisée dans l'IA médicale. Cette collaboration vise à accélérer l'adoption de diagnostics de précision et de soins à valeur ajoutée en fournissant aux professionnels de santé des données patients unifiées et des analyses avancées, améliorant ainsi les résultats des patients grâce à des interventions personnalisées et rapides.
En février 2025, BD a annoncé son intention de séparer ses activités Biosciences et Solutions diagnostiques afin de renforcer sa stratégie, de stimuler la croissance et de créer de la valeur. Cette opération vise à créer deux entités indépendantes, chacune mieux positionnée pour capitaliser sur ses marchés respectifs. Cette décision souligne l'engagement de BD à renforcer son leadership en matière d'innovation dans le secteur de la santé tout en optimisant son efficacité opérationnelle pour assurer sa réussite à long terme.
En novembre 2023, Binx Health s'est associé à Fisher Healthcare pour étendre la distribution de binx io, une plateforme moléculaire de détection de la chlamydia et de la gonorrhée au point de service, approuvée par la FDA. Ce système fournit des résultats de qualité laboratoire en environ 30 minutes, améliorant ainsi la rapidité des diagnostics et permettant aux cliniciens de tester et de traiter les patients lors d'une seule consultation, améliorant ainsi l'accès aux soins.
En avril 2023, Binx Health étend son activité commerciale afin de répondre à la demande croissante pour sa plateforme binx io, approuvée par la FDA et exemptée des normes CLIA, qui détecte la chlamydia et la gonorrhée en 30 minutes. Cette solution moléculaire au point de service offre des performances équivalentes à celles d'un laboratoire central et répond au besoin urgent de dépistage des IST accessible et rapide, améliorant ainsi les soins aux États-Unis.

SKU-33910

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Cliquez sur l'image pour l'agrandir

Tableau de bord d'analyse de données interactif
Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
Accès d'analyste de recherche pour la personnalisation et les requêtes
Analyse de la concurrence avec tableau de bord interactif
Dernières actualités, mises à jour et analyse des tendances
Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence

Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE POINT-OF-CARE-TESTING (POCT) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 TYPE LIFELINE CURVE

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

4.3 HEALTHCARE ECONOMY

4.3.1 HEALTHCARE EXPENDITURE

4.3.2 CAPITAL EXPENDITURE

4.3.3 CAPEX TRENDS

4.3.4 CAPEX ALLOCATION

4.3.5 FUNDING SOURCES

4.3.6 INDUSTRY BENCHMARKS

4.3.7 GDP RATIO IN OVERALL GDP

4.3.8 HEALTHCARE SYSTEM STRUCTURE

4.3.9 GOVERNMENT POLICIES

4.3.10 ECONOMIC DEVELOPMENT

4.4 REIMBURSEMENT FRAMEWORK

4.5 OPPORTUNITY MAP ANALYSIS

4.6 VALUE CHAIN ANALYSIS

4.7 MICRO AND MACRO ECONOMIC FACTORS

4.7.1 CURRENT MARKET PENETRATION

4.7.2 GROWTH PROSPECTS

4.7.3 KEY PRICING STRATEGIES

4.8 TECHNOLOGY ROADMAP: EUROPE POINT OF CARE TESTING

5 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES

6.1.2 RISING INCIDENCE OF SUBSTANCE ABUSE

6.1.3 INCREASED ADOPTION OF TELEMEDICINE

6.1.4 ADVANCEMENTS TECHNOLOGIES ENHANCING POC TESTING WITH BIOSENSORS AND MOBILE INTEGRATION

6.2 RESTRAINTS

6.2.1 DATA SECURITY AND PRIVACY CONCERNS

6.2.2 LACK OF ACCURACY AND TECHNICAL CHALLENGES

6.3 OPPORTUNITIES

6.3.1 RISING AWARENESS AND ADVOCACY FOR POINT-OF-CARE TESTING

6.3.2 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS

6.3.3 EXPANDING PRODUCT RANGE FOR POINT-OF-CARE TESTING

6.4 CHALLENGES

6.4.1 LIMITED AWARENESS AND ACCEPTANCE

6.4.2 IMPACT OF HIGH MAINTENANCE COSTS THREATENING POINT-OF-CARE TESTING (POCT) SUSTAINABILITY IN LOW-RESOURCE SETTINGS

7 EUROPE POINT-OF-CARE TESTING (POCT) MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 GLUCOSE MONITORING PRODUCTS

7.2.1 SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES

7.2.1.1 Strips

7.2.1.2 Meters

7.2.1.3 Lancets and Lancing Devices

7.2.2 CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS

7.3 INFECTIOUS DISEASE TESTING PRODUCTS

7.3.1 COVID-19

7.3.2 HIV TESTING PRODUCTS

7.3.2.1 Testing Reagents

7.3.2.2 Testing Equipment

7.3.3 RESPIRATORY INFECTION TESTING PRODUCTS

7.3.4 SEXUALLY TRANSMITTED DISEASES (STD) TESTING

7.3.4.1 NAAT-Based Systems

7.3.4.2 NON–NAAT-Based Systems

7.3.5 HEPATITIS C TESTING PRODUCTS

7.3.5.1 HCV Antibody Tests

7.3.5.2 HCV Viral Load Tests

7.3.6 INFLUENZA TESTING PRODUCTS

7.3.6.1 Traditional Diagnostic Test

7.3.6.2 Molecular Diagnostic Assay

7.3.6.2.1 Rapid Influenza Diagnostic Test (RIDT)

7.3.6.2.2 Direct Fluorescent Antibody Test (DFAT)

7.3.6.2.3 Viral Culture

7.3.6.2.4 Serological Assay

7.3.6.3 RT-PCR

7.3.6.4 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)

7.3.6.5 Nucleic Acid Sequence-Based Amplification Test (NASBAT)

7.3.6.6 Simple Amplification-Based Assay (SAMBA)

7.3.6.7 Healthcare Associated Infection (HAI) Testing

7.3.6.8 Tropical Disease Testing Products

7.3.6.9 Other Infectious Disease Testing Products

7.4 CARDIOMETABOLIC MONITORING PRODUCTS

7.4.1 CARDIAC MARKER TESTING PRODUCTS

7.4.1.1 HSTNL

7.4.1.2 BNP

7.4.1.3 D-DIMER

7.4.1.4 CK-MB

7.4.1.5 Myoglobin

7.4.2 BLOOD GAS/ELECTROLYTE TESTING PRODUCTS

7.4.2.1 Blood Gas/Electrolyte Testing Consumables

7.4.2.2 Blood Gas/Electrolyte Testing Instruments

7.4.3 CARTRIDGES

7.4.4 REAGENTS

7.4.4.1 Portable

7.4.4.2 Benchtop

7.4.4.3 Combined Analyzers

7.4.4.4 Blood Gas Analyzers

7.4.4.5 Electrolyte Analyzers

7.4.4.6 Combined Analyzers

7.4.4.7 Blood Gas Analyzers

7.4.4.8 Electrolyte Analyzers

7.4.5 HBA1C TESTING PRODUCTS

7.4.5.1 HBA1C Testing Instruments

7.4.5.2 HBA1C Testing Consumables

7.4.5.3 POC Analyzer

7.4.5.4 ECG Device

7.4.5.5 Resting ECG Devices

7.4.5.6 Stress ECG Devices

7.4.5.7 Holter Monitors

7.5 PREGNANCY AND FERTILITY TESTING PRODUCTS

7.5.1 PREGNANCY TESTING PRODUCTS

7.5.1.1 Strips/ Dip Sticks and Cards

7.5.1.2 Mid Stream Devices

7.5.1.3 Cassettes

7.5.1.4 Digital Devices

7.5.1.5 Line-Indicator Devices

7.5.2 FERTILITY TESTING PRODUCTS

7.5.2.1 Luteinizing Hormone (LH) Urine Test

7.5.2.2 FSH Test

7.5.2.3 others

7.6 HAEMATOLOGY TESTING PRODUCTS

7.7 COAGULATION MONITORING PRODUCTS

7.7.1 ANTICOAGULATION MONITORING DEVICES

7.7.1.1 Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices

7.7.1.2 Activated Clotting Time (ACT)

7.7.1.3 Activated Partial Thromboplastin Time (APPT)

7.7.1.4 Platelet Function Monitoring Devices

7.7.1.5 Viscoelastic Coagulation Monitoring Devices

7.7.1.6 Rotational Thromboelastometry (ROTEM)

7.7.1.7 Thromboelastography (TEG)

7.7.1.8 Drug-Of-Abuse (DOA) Testing Products

7.7.2 DOA ANALYSERS

7.7.2.1 Immunoassays

7.7.2.2 Chromatographic Devices

7.7.2.3 Breath Analysers

7.7.3 RAPID TESTING DEVICES

7.7.3.1 Urine Testing Devices

7.7.3.2 Oral Fluid Testing Devices

7.7.3.4 Others

7.8 URINALYSIS TESTING PRODUCTS

7.8.1.1 POC Urine Strip Self-Testing

7.8.1.2 POC Urine Test Strip Professional Testing

7.9 CHOLESTEROL TESTING PRODUCTS

7.9.1.1 Testing Kits

7.9.1.2 Instruments

7.9.1.3 Table-Top Analyzers

7.9.1.4 Hand-Held Analyzers

7.1 TUMOR/CANCER MARKER TESTING PRODUCTS

7.11 FECAL OCCULT TESTING PRODUCTS

7.11.1.1 Guaiac FOB Stool Test

7.11.1.2 Lateral Flow Immuno-FOB Test

7.11.1.3 Immuno-FOB Agglutination Test

7.11.1.4 Immuno-FOB ELISA Test

7.12 OTHERS

8 EUROPE POINT-OF-CARE TESTING (POCT) MARKET, BY PLATFORM

8.1 OVERVIEW

8.2 LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS

8.3 IMMUNOASSAYS

8.4 DIPSTICKS

8.5 MOLECULAR DIAGNOSTICS

8.6 CLINICAL CHEMISTRY ASSAYS

8.7 MICROFLUIDICS

8.8 HEMATOLOGY

8.9 OTHERS

9 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 BLOOD GLUCOSE

9.3 INFECTIOUS DISEASES

9.3.1 COVID-19 TESTING

9.3.2 HIV TESTING

9.3.3 HEPATITIS C TESTING

9.3.4 INFLUENZA TESTING

9.3.5 TUBERCULOSIS TESTING

9.3.6 OTHERS

9.4 VITAL SIGN MONITORING

9.5 CARDIAC MONITORING

9.6 COAGULATION

9.7 HAEMATOLOGY

9.8 NON- INVASIVE SPO2 MONITORING

9.9 BLOOD TRANSFUSION

9.1 NON- INVASIVE PCO2 MONITORING

9.11 WHOLE BLOOD ANALYSIS

9.12 OTHERS

10 EUROPE POINT-OF-CARE TESTING (POCT) MARKET, BY PRESCRIPTION MODE

10.1 OVERVIEW

10.2 OTC TESTING

10.3 PRESCRIPTION-BASED TESTING

11 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 RETAIL SALES

11.4 ONLINE SALES

11.5 OTHERS

12 EUROPE POINT-OF-CARE TESTING (POCT) MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 PRIVATE

12.2.1.1 Tier 1

12.2.1.2 Tier 2

12.2.1.3 Tier 3

12.2.2 PUBLIC

12.2.2.1 Tier 1

12.2.2.2 Tier 2

12.2.2.3 Tier 3

12.3 HOME CARE

12.4 CLINICS

12.5 LABORATORIES

12.6 DIAGNOSTIC CENTERS

12.7 PATHOLOGY LABS

12.8 AMBULATORY SURGERY CENTERS

12.9 ELDERLY CARE CENTERS

12.1 OTHERS

13 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION

13.1 EUROPE

13.1.1 GERMANY

13.1.2 FRANCE

13.1.3 U.K.

13.1.4 ITALY

13.1.5 SPAIN

13.1.6 RUSSIA

13.1.7 TURKEY

13.1.8 NETHERLANDS

13.1.9 SWITZERLAND

13.1.10 NORWAY

13.1.11 POLAND

13.1.12 REST OF EUROPE

14 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: GLOBAL

15 SWOT ANALYSIS

16 COMPANY PROFILES

16.1 ABBOTT POINT OF CARE INC(ABBOTT)

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENT

16.2 SINOCARE.

16.2.1 COMPANY SNAPSHOT

16.2.2 COMPANY SHARE ANALYSIS

16.2.3 PRODUCT PORTFOLIO

16.2.4 RECENT DEVELOPMENT

16.3 F. HOFFMANN-LA ROCHE LTD

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 DANAHER

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 HOLOGIC, INC

16.5.1 COMPANY SNAPSHOT

16.5.2 REVENUE ANALYSIS

16.5.3 COMPANY SHARE ANALYSIS

16.5.4 PRODUCT PORTFOLIO

16.5.5 RECENT DEVELOPMENT

16.6 ACCUBIOTECH CO., LTD.

16.6.1 COMPANY SNAPSHOT

16.6.2 PRODUCT PORTFOLIO

16.6.3 RECENT DEVELOPMENT

16.7 ABAXIS (ABAXIS IS A PART OF ZOETIS)

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENT

16.8 AUTOBIO

16.8.1 COMPANY SNAPSHOT

16.8.2 REVENUE ANALYSIS

16.8.3 PRODUCT PORTFOLIO

16.8.4 RECENT DEVELOPMENT

16.9 BD VERITOR(BD)

16.9.1 COMPANY SNAPSHOT

16.9.2 REVENUE ANALYSIS

16.9.3 PRODUCT PORTFOLIO

16.9.4 RECENT DEVELOPMENT

16.1 BINX HEALTH

16.10.1 COMPANY SNAPSHOT

16.10.2 SOLUTION PORTFOLIO

16.10.3 RECENT DEVELOPMENT

16.11 BIOMERIEUX

16.11.1 COMPANY SNAPSHOT

16.11.2 REVENUE ANALYSIS

16.11.3 PRODUCT PORTFOLIO

16.11.4 RECENT DEVELOPMENT

16.12 BIO- RAD LABORATORIES, INC.

16.12.1 COMPANY SNAPSHOT

16.12.2 REVENUE ANALYSIS

16.12.3 PRODUCT PORTFOLIO

16.12.4 RECENT DEVELOPMENT

16.13 CHEMBIO DIAGNOSTICS, INC.

16.13.1 COMPANY SNAPSHOT

16.13.2 PRODUCT PORTFOLIO

16.13.3 RECENT DEVELOPMENT

16.14 EKF DIAGNOSTICS HOLDINGS PLC

16.14.1 COMPANY SNAPSHOT

16.14.2 REVENUE ANALYSIS

16.14.3 PRODUCT PORTFOLIO

16.14.4 RECENT DEVELOPMENT

16.15 GETEIN BIOTECH, INC.

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENT

16.16 LAMDAGEN CORPORATION

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 MERIDIAN BIOSCIENCE

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENT

16.18 NOVA BIOMEDICAL

16.18.1 COMPANY SNAPSHOT

16.18.2 PRODUCT PORTFOLIO

16.18.3 RECENT DEVELOPMENT

16.19 PFIZER INC.

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENT

16.2 PTS DIAGNOSTICS

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 QIAGEN

16.21.1 COMPANY SNAPSHOT

16.21.2 REVENUE ANALYSIS

16.21.3 PRODUCT PORTFOLIO

16.21.4 RECENT DEVELOPMENT

16.22 QUIDELORTHO CORPORATION

16.22.1 COMPANY SNAPSHOT

16.22.2 REVENUE ANALYSIS

16.22.3 PRODUCT PORTFOLIO

16.22.4 RECENT DEVELOPMENT

16.23 QUANTUMDX GROUP LTD.

16.23.1 COMPANY SNAPSHOT

16.23.2 PRODUCT PORTFOLIO

16.23.3 RECENT DEVELOPMENT

16.24 SEKISUI DIAGNOSTICS

16.24.1 COMPANY SNAPSHOT

16.24.2 PRODUCT PORTFOLIO

16.24.3 RECENT. DEVELOPMENT

16.25 SHENZHEN NEW INDUSTRY BIOMEDICAL ENGINEERING CO., LTD.

16.25.1 COMPANY SNAPSHOT

16.25.2 REVENUE ANALYSIS

16.25.3 PRODUCT PORTFOLIO

16.25.4 RECENT DEVELOPMENT

16.26 SIEMENS HEALTHINEERS AG

16.26.1 COMPANY SNAPSHOT

16.26.2 REVENUE ANALYSIS

16.26.3 PRODUCT PORTFOLIO

16.26.4 RECENT DEVELOPMENT

16.27 SIENCO, INC.

16.27.1 COMPANY SNAPSHOT

16.27.2 PRODUCT PORTFOLIO

16.27.3 RECENT UPDATES

16.28 SYSMEX CORPORATION

16.28.1 COMPANY SNAPSHOT

16.28.2 REVENUE ANALYSIS

16.28.3 PRODUCT PORTFOLIO

16.28.4 RECENT DEVELOPMENT

16.29 TRINITY BIOTECH

16.29.1 COMPANY SNAPSHOT

16.29.2 REVENUE ANALYSIS

16.29.3 PR.ODUCT PORTFOLIO

16.29.4 RECENT DEVELOPMENT

16.3 TRIVIDIA HEALTH, INC.

16.30.1 COMPANY SNAPSHOT

16.30.2 PRODUCT PORTFOLIO

16.30.3 RECENT UPDATES

16.31 THERMO FISHER SCIENTIFIC INC.

16.31.1 COMPANY SNAPSHOT

16.31.2 REVENUE ANALYSIS

16.31.3 PRODUCT PORTFOLIO

16.31.4 RECENT DEVELOPMENT

16.32 WERFEN

16.32.1 COMPANY SNAPSHOT

16.32.2 PRODUCT PORTFOLIO

16.32.3 RECENT DEVELOPMENT

16.33 WONDFO

16.33.1 COMPANY SNAPSHOT

16.33.2 REVENUE ANALYSIS

16.33.3 PRODUCT PORTFOLIO

16.33.4 RECENT DEVELOPMENT

16.34 XIAMEN BOSON BIOTECH CO., LTD.

16.34.1 COMPANY SNAPSHOT

16.34.2 PRODUCT PORTFOLIO

16.34.3 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

Liste des tableaux

TABLE 1 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 2 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 3 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 4 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 5 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 6 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 7 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 8 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 9 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 10 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 11 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 12 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 13 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)

TABLE 14 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 15 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 16 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 17 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 18 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 19 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 20 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 21 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 22 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 23 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 24 EUROPE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 25 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 26 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 27 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 28 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 29 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 30 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 31 EUROPE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 32 EUROPE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 33 EUROPE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 34 EUROPE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 35 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 36 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 37 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 38 EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 39 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 40 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 41 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 42 EUROPE BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 43 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 44 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 45 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 46 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 47 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 48 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 49 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 50 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 51 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 52 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 53 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 54 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 55 EUROPE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 56 EUROPE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 57 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 58 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)

TABLE 59 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 60 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 61 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 62 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 63 EUROPE HAEMATOLOGY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 64 EUROPE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 65 EUROPE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 66 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 67 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 68 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 69 EUROPE VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSANDS)

TABLE 70 EUROPE DRUGS-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 71 EUROPE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 72 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 73 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 74 EUROPE DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 75 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 76 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 77 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 78 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 79 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 80 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 81 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 82 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 83 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 84 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)

TABLE 85 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 86 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)

TABLE 87 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 88 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 89 EUROPE TUMOR/CANCER MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 90 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 91 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 92 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSANDS UNITS)

TABLE 93 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 94 EUROPE OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 95 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 96 EUROPE LATERAL FLOW ASSAYS/IMMUNOCHROMATOGRAPHY TESTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 97 EUROPE IMMUNOASSAYS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 98 EUROPE DIPSTICKS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 99 EUROPE MOLECULAR DIAGNOSTICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 100 EUROPE CLINICAL CHEMISTRY ASSAYS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 101 EUROPE MICROFLUIDICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 102 EUROPE HEMATOLOGY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 103 EUROPE OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 104 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 105 EUROPE BLOOD GLUCOSE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 106 EUROPE INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 107 EUROPE INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 108 EUROPE VITAL SIGN MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 109 EUROPE CARDIAC MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 110 EUROPE COAGULATION IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 111 EUROPE HAEMATOLOGY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 112 EUROPE NON- INVASIVE SPO2 MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 113 EUROPE BLOOD TRANSFUSION IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 114 EUROPE NON- INVASIVE PCO2 MONITORING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 115 EUROPE WHOLE BLOOD ANALYSIS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 116 EUROPE OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 117 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSANDS)

TABLE 118 EUROPE OTC TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSAND)

TABLE 119 EUROPE PRESCRIPTION-BASED TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD THOUSANDS)

TABLE 120 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD MILLION)

TABLE 121 EUROPE DIRECT TENDER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)

TABLE 122 EUROPE RETAIL SALES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)

TABLE 123 EUROPE ONLINE SALES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)

TABLE 124 EUROPE OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2033 (USD MILLIONS)

TABLE 125 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2032 (USD THOUSAND)

TABLE 126 EUROPE HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSANDS)

TABLE 127 EUROPE HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2032 (USD THOUSANDS)

TABLE 128 EUROPE PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSANDS)

TABLE 129 EUROPE PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2032 (USD THOUSANDS)

TABLE 130 EUROPE HOME CARE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 131 EUROPE CLINICS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 132 EUROPE LABORATORIES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 133 EUROPE DIAGNOSTIC CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 134 EUROPE PATHOLOGY LABS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 135 EUROPE AMBULATORY SURGERY CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 136 EUROPE ELDERLY CARE CENTERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 137 EUROPE OTHERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 138 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)

TABLE 139 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)

TABLE 140 EUROPE

TABLE 141 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 142 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 143 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 144 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 145 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 146 EUROPE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 147 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 148 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 149 EUROPE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 150 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 151 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 152 EUROPE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 153 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 154 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 155 EUROPE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 156 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 157 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 158 EUROPE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 159 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 160 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 161 EUROPE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 162 EUROPE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 163 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 164 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 165 EUROPE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 166 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 167 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 168 EUROPE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 169 EUROPE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 170 EUROPE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 171 EUROPE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 172 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 173 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 174 EUROPE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 175 EUROPE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 176 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 177 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 178 EUROPE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 179 EUROPE BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 180 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 181 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 182 EUROPE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 183 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 184 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 185 EUROPE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 186 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 187 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 188 EUROPE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 189 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 190 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 191 EUROPE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 192 EUROPE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 193 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 194 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 195 EUROPE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 196 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 197 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 198 EUROPE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 199 EUROPE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 200 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 201 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 202 EUROPE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 203 EUROPE VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 204 EUROPE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 205 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 206 EUROPE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 207 EUROPE DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 208 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 209 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 210 EUROPE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 211 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 212 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 213 EUROPE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 214 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 215 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 216 EUROPE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 217 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 218 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 219 EUROPE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 220 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 221 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 222 EUROPE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 223 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 224 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 225 EUROPE INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 226 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 227 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 228 EUROPE HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 229 EUROPE PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 230 EUROPE PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 231 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 232 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 233 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 234 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 235 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 236 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 237 GERMANY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 238 GERMANY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 239 GERMANY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 240 GERMANY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 241 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 242 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 243 GERMANY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 244 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 245 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 246 GERMANY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 247 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 248 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 249 GERMANY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 250 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 251 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 252 GERMANY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 253 GERMANY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 254 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 255 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 256 GERMANY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 257 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 258 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 259 GERMANY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 260 GERMANY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 261 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 262 GERMANY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 263 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 264 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 265 GERMANY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 266 GERMANY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 267 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 268 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 269 GERMANY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 270 GERMANY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 271 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 272 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 273 GERMANY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 274 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 275 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 276 GERMANY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 277 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 278 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 279 GERMANY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 280 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 281 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 282 GERMANY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 283 GERMANY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 284 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 285 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 286 GERMANY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 287 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 288 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 289 GERMANY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 290 GERMANY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 291 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 292 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 293 GERMANY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 294 GERMANY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 295 GERMANY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 296 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 297 GERMANY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 298 GERMANY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 299 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 300 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 301 GERMANY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 302 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 303 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 304 GERMANY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 305 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 306 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 307 GERMANY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 308 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 309 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 310 GERMANY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 311 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 312 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 313 GERMANY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 314 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 315 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 316 GERMANY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 317 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 318 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 319 GERMANY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 320 GERMANY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 321 GERMANY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 322 GERMANY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 323 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 324 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 325 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 326 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 327 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 328 FRANCE GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 329 FRANCE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 330 FRANCE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 331 FRANCE SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 332 FRANCE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 333 FRANCE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 334 FRANCE INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 335 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 336 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 337 FRANCE HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 338 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 339 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 340 FRANCE SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 341 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 342 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 343 FRANCE HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 344 FRANCE INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 345 FRANCE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 346 FRANCE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 347 FRANCE TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 348 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 349 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 350 FRANCE MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 351 FRANCE CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 352 FRANCE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 353 FRANCE POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 354 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 355 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 356 FRANCE CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 357 FRANCE BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 358 FRANCE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 359 FRANCE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 360 FRANCE BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 361 FRANCE BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 362 FRANCE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 363 FRANCE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 364 FRANCE PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 365 FRANCE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 366 FRANCE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 367 FRANCE BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 368 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 369 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 370 FRANCE HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 371 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 372 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 373 FRANCE ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 374 FRANCE PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 375 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 376 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 377 FRANCE PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 378 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 379 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 380 FRANCE FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 381 FRANCE COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 382 FRANCE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 383 FRANCE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 384 FRANCE ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 385 FRANCE VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 386 FRANCE DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 387 FRANCE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 388 FRANCE DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 389 FRANCE DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 390 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 391 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 392 FRANCE RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 393 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 394 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 395 FRANCE URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 396 FRANCE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 397 FRANCE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 398 FRANCE CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 399 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 400 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 401 FRANCE INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 402 FRANCE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 403 FRANCE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 404 FRANCE FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 405 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 406 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 407 FRANCE INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 408 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 409 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 410 FRANCE HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 411 FRANCE PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 412 FRANCE PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 413 FRANCE POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 414 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 415 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 416 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 417 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 418 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 419 U.K. GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 420 U.K. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 421 U.K. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 422 U.K. SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 423 U.K. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 424 U.K. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 425 U.K. INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 426 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 427 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 428 U.K. HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 429 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 430 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 431 U.K. SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 432 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 433 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 434 U.K. HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 435 U.K. INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 436 U.K. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 437 U.K. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 438 U.K. TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 439 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 440 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 441 U.K. MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 442 U.K. CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 443 U.K. POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 444 U.K. POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 445 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 446 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 447 U.K. CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 448 U.K. BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 449 U.K. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 450 U.K. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 451 U.K. BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 452 U.K. BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 453 U.K. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 454 U.K. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 455 U.K. PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 456 U.K. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 457 U.K. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 458 U.K. BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 459 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 460 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 461 U.K. HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 462 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 463 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 464 U.K. ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 465 U.K. PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 466 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 467 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 468 U.K. PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 469 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 470 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 471 U.K. FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 472 U.K. COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 473 U.K. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 474 U.K. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 475 U.K. ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 476 U.K. VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 477 U.K. DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 478 U.K. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 479 U.K. DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 480 U.K. DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 481 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 482 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 483 U.K. RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 484 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 485 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 486 U.K. URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 487 U.K. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 488 U.K. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 489 U.K. CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 490 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 491 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 492 U.K. INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 493 U.K. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 494 U.K. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 495 U.K. FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 496 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 497 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 498 U.K. INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 499 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 500 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 501 U.K. HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 502 U.K. PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 503 U.K. PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 504 U.K. POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 505 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 506 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 507 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 508 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 509 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 510 ITALY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 511 ITALY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 512 ITALY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 513 ITALY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 514 ITALY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 515 ITALY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 516 ITALY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 517 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 518 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 519 ITALY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 520 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 521 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 522 ITALY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 523 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 524 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 525 ITALY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 526 ITALY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 527 ITALY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 528 ITALY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 529 ITALY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 530 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 531 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 532 ITALY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 533 ITALY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 534 ITALY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 535 ITALY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 536 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 537 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 538 ITALY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 539 ITALY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 540 ITALY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 541 ITALY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 542 ITALY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 543 ITALY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 544 ITALY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 545 ITALY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 546 ITALY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 547 ITALY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 548 ITALY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 549 ITALY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 550 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 551 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 552 ITALY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 553 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 554 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 555 ITALY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 556 ITALY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 557 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 558 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 559 ITALY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 560 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 561 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 562 ITALY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 563 ITALY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 564 ITALY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 565 ITALY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 566 ITALY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 567 ITALY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 568 ITALY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 569 ITALY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 570 ITALY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 571 ITALY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 572 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 573 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 574 ITALY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 575 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 576 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 577 ITALY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 578 ITALY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 579 ITALY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 580 ITALY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 581 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 582 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 583 ITALY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 584 ITALY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 585 ITALY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 586 ITALY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 587 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 588 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 589 ITALY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 590 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 591 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 592 ITALY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 593 ITALY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 594 ITALY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 595 ITALY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 596 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 597 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 598 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 599 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 600 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 601 SPAIN GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 602 SPAIN SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 603 SPAIN SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 604 SPAIN SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 605 SPAIN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 606 SPAIN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 607 SPAIN INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 608 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 609 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 610 SPAIN HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 611 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 612 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 613 SPAIN SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 614 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 615 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 616 SPAIN HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 617 SPAIN INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 618 SPAIN TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 619 SPAIN TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 620 SPAIN TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 621 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 622 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 623 SPAIN MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 624 SPAIN CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 625 SPAIN POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 626 SPAIN POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 627 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 628 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 629 SPAIN CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 630 SPAIN BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 631 SPAIN BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 632 SPAIN BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 633 SPAIN BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 634 SPAIN BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 635 SPAIN PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 636 SPAIN PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 637 SPAIN PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 638 SPAIN BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 639 SPAIN BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 640 SPAIN BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 641 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 642 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 643 SPAIN HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 644 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 645 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 646 SPAIN ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 647 SPAIN PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 648 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 649 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 650 SPAIN PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 651 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 652 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 653 SPAIN FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 654 SPAIN COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 655 SPAIN ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 656 SPAIN ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 657 SPAIN ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 658 SPAIN VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 659 SPAIN DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 660 SPAIN DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 661 SPAIN DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 662 SPAIN DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 663 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 664 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 665 SPAIN RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 666 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 667 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 668 SPAIN URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 669 SPAIN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 670 SPAIN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 671 SPAIN CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 672 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 673 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 674 SPAIN INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 675 SPAIN FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 676 SPAIN FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 677 SPAIN FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 678 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 679 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 680 SPAIN INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 681 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 682 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 683 SPAIN HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 684 SPAIN PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 685 SPAIN PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 686 SPAIN POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 687 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 688 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 689 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 690 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 691 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 692 RUSSIA GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 693 RUSSIA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 694 RUSSIA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 695 RUSSIA SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 696 RUSSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 697 RUSSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 698 RUSSIA INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 699 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 700 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 701 RUSSIA HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 702 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 703 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 704 RUSSIA SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 705 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 706 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 707 RUSSIA HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 708 RUSSIA INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 709 RUSSIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 710 RUSSIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 711 RUSSIA TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 712 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 713 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 714 RUSSIA MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 715 RUSSIA CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 716 RUSSIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 717 RUSSIA POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 718 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 719 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 720 RUSSIA CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 721 RUSSIA BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 722 RUSSIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 723 RUSSIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 724 RUSSIA BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 725 RUSSIA BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 726 RUSSIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 727 RUSSIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 728 RUSSIA PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 729 RUSSIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 730 RUSSIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 731 RUSSIA BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 732 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 733 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 734 RUSSIA HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 735 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 736 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 737 RUSSIA ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 738 RUSSIA PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 739 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 740 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 741 RUSSIA PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 742 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 743 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 744 RUSSIA FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 745 RUSSIA COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 746 RUSSIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 747 RUSSIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 748 RUSSIA ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 749 RUSSIA VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 750 RUSSIA DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 751 RUSSIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 752 RUSSIA DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 753 RUSSIA DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 754 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 755 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 756 RUSSIA RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 757 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 758 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 759 RUSSIA URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 760 RUSSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 761 RUSSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 762 RUSSIA CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 763 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 764 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 765 RUSSIA INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 766 RUSSIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 767 RUSSIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 768 RUSSIA FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 769 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 770 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 771 RUSSIA INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 772 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 773 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 774 RUSSIA HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 775 RUSSIA PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 776 RUSSIA PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 777 RUSSIA POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 778 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 779 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 780 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 781 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 782 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 783 TURKEY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 784 TURKEY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 785 TURKEY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 786 TURKEY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 787 TURKEY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 788 TURKEY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 789 TURKEY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 790 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 791 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 792 TURKEY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 793 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 794 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 795 TURKEY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 796 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 797 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 798 TURKEY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 799 TURKEY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 800 TURKEY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 801 TURKEY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 802 TURKEY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 803 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 804 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 805 TURKEY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 806 TURKEY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 807 TURKEY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 808 TURKEY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 809 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 810 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 811 TURKEY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 812 TURKEY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 813 TURKEY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 814 TURKEY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 815 TURKEY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 816 TURKEY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 817 TURKEY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 818 TURKEY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 819 TURKEY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 820 TURKEY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 821 TURKEY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 822 TURKEY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 823 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 824 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 825 TURKEY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 826 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 827 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 828 TURKEY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 829 TURKEY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 830 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 831 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 832 TURKEY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 833 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 834 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 835 TURKEY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 836 TURKEY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 837 TURKEY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 838 TURKEY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 839 TURKEY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 840 TURKEY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 841 TURKEY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 842 TURKEY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 843 TURKEY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 844 TURKEY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 845 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 846 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 847 TURKEY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 848 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 849 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 850 TURKEY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 851 TURKEY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 852 TURKEY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 853 TURKEY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 854 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 855 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 856 TURKEY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 857 TURKEY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 858 TURKEY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 859 TURKEY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 860 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 861 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 862 TURKEY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 863 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 864 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 865 TURKEY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 866 TURKEY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 867 TURKEY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 868 TURKEY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 869 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 870 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 871 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 872 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 873 NETHERLANDS GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 874 NETHERLANDS SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 875 NETHERLANDS SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 876 NETHERLANDS SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 877 NETHERLANDS SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 878 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 879 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 880 NETHERLANDS INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 881 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 882 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 883 NETHERLANDS HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 884 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 885 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 886 NETHERLANDS SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 887 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 888 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 889 NETHERLANDS HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 890 NETHERLANDS INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 891 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 892 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 893 NETHERLANDS TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 894 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 895 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 896 NETHERLANDS MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 897 NETHERLANDS CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 898 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 899 NETHERLANDS POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 900 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 901 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 902 NETHERLANDS CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 903 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 904 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 905 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 906 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 907 NETHERLANDS BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 908 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 909 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 910 NETHERLANDS PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 911 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 912 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 913 NETHERLANDS BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 914 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 915 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 916 NETHERLANDS HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 917 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 918 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 919 NETHERLANDS ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 920 NETHERLANDS PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 921 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 922 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 923 NETHERLANDS PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 924 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 925 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 926 NETHERLANDS FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 927 NETHERLANDS COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 928 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 929 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 930 NETHERLANDS ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 931 NETHERLANDS VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 932 NETHERLANDS DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 933 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 934 NETHERLANDS DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 935 NETHERLANDS DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 936 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 937 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 938 NETHERLANDS RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 939 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 940 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 941 NETHERLANDS URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 942 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 943 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 944 NETHERLANDS CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 945 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 946 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 947 NETHERLANDS INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 948 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 949 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 950 NETHERLANDS FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 951 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 952 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 953 NETHERLANDS INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 954 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 955 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 956 NETHERLANDS HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 957 NETHERLANDS PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 958 NETHERLANDS PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 959 NETHERLANDS POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 960 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 961 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 962 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 963 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 964 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 965 SWITZERLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 966 SWITZERLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 967 SWITZERLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 968 SWITZERLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 969 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 970 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 971 SWITZERLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 972 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 973 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 974 SWITZERLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 975 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 976 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 977 SWITZERLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 978 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 979 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 980 SWITZERLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 981 SWITZERLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 982 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 983 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 984 SWITZERLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 985 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 986 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 987 SWITZERLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 988 SWITZERLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 989 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 990 SWITZERLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 991 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 992 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 993 SWITZERLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 994 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 995 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 996 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 997 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 998 SWITZERLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 999 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1000 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1001 SWITZERLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1002 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1003 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1004 SWITZERLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1005 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1006 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1007 SWITZERLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1008 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1009 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1010 SWITZERLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1011 SWITZERLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1012 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1013 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1014 SWITZERLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1015 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1016 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1017 SWITZERLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1018 SWITZERLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1019 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1020 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1021 SWITZERLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1022 SWITZERLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 1023 SWITZERLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1024 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1025 SWITZERLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1026 SWITZERLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1027 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1028 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1029 SWITZERLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1030 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1031 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1032 SWITZERLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1033 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1034 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1035 SWITZERLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1036 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1037 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1038 SWITZERLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1039 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1040 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1041 SWITZERLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1042 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 1043 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 1044 SWITZERLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1045 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 1046 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 1047 SWITZERLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1048 SWITZERLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1049 SWITZERLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1050 SWITZERLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 1051 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1052 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1053 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1054 NORWAY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1055 NORWAY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1056 NORWAY GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1057 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1058 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1059 NORWAY SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1060 NORWAY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1061 NORWAY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1062 NORWAY INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1063 NORWAY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1064 NORWAY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1065 NORWAY HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1066 NORWAY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1067 NORWAY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1068 NORWAY SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1069 NORWAY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1070 NORWAY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1071 NORWAY HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1072 NORWAY INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1073 NORWAY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1074 NORWAY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1075 NORWAY TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1076 NORWAY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1077 NORWAY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1078 NORWAY MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1079 NORWAY CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1080 NORWAY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1081 NORWAY POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1082 NORWAY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1083 NORWAY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1084 NORWAY CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1085 NORWAY BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1086 NORWAY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1087 NORWAY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1088 NORWAY BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1089 NORWAY BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1090 NORWAY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1091 NORWAY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1092 NORWAY PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1093 NORWAY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1094 NORWAY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1095 NORWAY BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1096 NORWAY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1097 NORWAY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1098 NORWAY HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1099 NORWAY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1100 NORWAY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1101 NORWAY ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1102 NORWAY PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1103 NORWAY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1104 NORWAY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1105 NORWAY PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1106 NORWAY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1107 NORWAY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1108 NORWAY FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1109 NORWAY COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1110 NORWAY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1111 NORWAY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1112 NORWAY ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1113 NORWAY VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 1114 NORWAY DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1115 NORWAY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1116 NORWAY DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1117 NORWAY DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1118 NORWAY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1119 NORWAY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1120 NORWAY RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1121 NORWAY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1122 NORWAY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1123 NORWAY URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1124 NORWAY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1125 NORWAY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1126 NORWAY CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1127 NORWAY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1128 NORWAY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1129 NORWAY INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1130 NORWAY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1131 NORWAY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1132 NORWAY FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1133 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 1134 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 1135 NORWAY INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1136 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 1137 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 1138 NORWAY HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1139 NORWAY PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1140 NORWAY PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1141 NORWAY POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 1142 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1143 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1144 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1145 POLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1146 POLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1147 POLAND GLUCOSE MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1148 POLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1149 POLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1150 POLAND SELF-MONITORING OF BLOOD GLUCOSE (SMBG) DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1151 POLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1152 POLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1153 POLAND INFECTIOUS DISEASE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1154 POLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1155 POLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1156 POLAND HIV TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1157 POLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1158 POLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1159 POLAND SEXUALLY TRANSMITTED DISEASES (STD) TESTING IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1160 POLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1161 POLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1162 POLAND HEPATITIS C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1163 POLAND INFLUENZA TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1164 POLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1165 POLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1166 POLAND TRADITIONAL DIAGNOSTIC TEST IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1167 POLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1168 POLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1169 POLAND MOLECULAR DIAGNOSTIC ASSAY IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1170 POLAND CARDIOMETABOLIC MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1171 POLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1172 POLAND POC ANALYZER IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1173 POLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1174 POLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1175 POLAND CARDIAC MARKER TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1176 POLAND BLOOD GAS/ELECTROLYTE TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1177 POLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1178 POLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1179 POLAND BLOOD GAS/ELECTROLYTE TESTING CONSUMABLES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1180 POLAND BLOOD GAS/ELECTROLYTE TESTING INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1181 POLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1182 POLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1183 POLAND PORTABLE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1184 POLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1185 POLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1186 POLAND BENCHTOP IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1187 POLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1188 POLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1189 POLAND HBA1C TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1190 POLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1191 POLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1192 POLAND ECG DEVICE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1193 POLAND PREGNANCY AND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1194 POLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1195 POLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1196 POLAND PREGNANCY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1197 POLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1198 POLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1199 POLAND FERTILITY TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1200 POLAND COAGULATION MONITORING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1201 POLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1202 POLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1203 POLAND ANTICOAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1204 POLAND VISCOELASTIC COAGULATION MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY METHOD, 2018-2033 (USD THOUSAND)

TABLE 1205 POLAND DRUG-OF-ABUSE (DOA) TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1206 POLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1207 POLAND DOA ANALYZERS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1208 POLAND DOA ANALYZERS MONITORING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1209 POLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1210 POLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1211 POLAND RAPID TESTING DEVICES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1212 POLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1213 POLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1214 POLAND URINALYSIS TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1215 POLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1216 POLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1217 POLAND CHOLESTEROL TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1218 POLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1219 POLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1220 POLAND INSTRUMENTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1221 POLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1222 POLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1223 POLAND FECAL OCCULT TESTING PRODUCTS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

TABLE 1224 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PLATFORM, 2018-2033 (USD THOUSAND)

TABLE 1225 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY APPLICATION, 2018-2033 (USD THOUSAND)

TABLE 1226 POLAND INFECTIOUS DISEASES IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1227 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY PRESCRIPTION MODE, 2018-2033 (USD THOUSAND)

TABLE 1228 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY END USER, 2018-2033 (USD THOUSAND)

TABLE 1229 POLAND HOSPITALS IN POINT-OF-CARE-TESTING (POCT) MARKET, BY TYPE, 2018-2033 (USD THOUSAND)

TABLE 1230 POLAND PRIVATE IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1231 POLAND PUBLIC IN POINT-OF-CARE-TESTING (POCT) MARKET, BY LEVEL, 2018-2033 (USD THOUSAND)

TABLE 1232 POLAND POINT-OF-CARE-TESTING (POCT) MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)

TABLE 1233 REST OF EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)

TABLE 1234 REST OF EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (VOLUME IN THOUSAND UNITS)

TABLE 1235 REST OF EUROPE POINT-OF-CARE-TESTING (POCT) MARKET, BY PRODUCT TYPE, 2018-2033 (ASP IN USD/UNITS)

Liste des figures

FIGURE 1 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 2 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DROC ANALYSIS

FIGURE 4 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SEGMENTATION

FIGURE 11 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS

FIGURE 13 RISING USE OF POC TESTING IN HEALTHCARE FACILITIES IS EXPECTED TO DRIVE THE GROWTH OF EUROPE POINT-OF-CARE-TESTING (POCT) MARKET FROM 2026 TO 2033

FIGURE 14 THE GLUCOSE MONITORING PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE POINT-OF-CARE-TESTING (POCT) MARKET IN 2026 - 2032

FIGURE 15 DRCO ANALYSIS

FIGURE 16 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2025

FIGURE 17 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, 2026-2033 (USD THOUSAND)

FIGURE 18 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, CAGR (2026-2033)

FIGURE 19 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2025

FIGURE 21 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, 2026 TO 2033 (USD THOUSAND)

FIGURE 22 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, CAGR (2026- 2033)

FIGURE 23 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 24 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2025

FIGURE 25 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, 2026 TO 2033 (USD THOUSAND)

FIGURE 26 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, CAGR (2026- 2033)

FIGURE 27 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 28 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2025

FIGURE 29 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, 2026 TO 2033 (USD THOUSAND)

FIGURE 30 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, CAGR (2026- 2033)

FIGURE 31 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY PRESCRIPTION MODE, LIFELINE CURVE

FIGURE 32 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2025

FIGURE 33 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)

FIGURE 34 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)

FIGURE 35 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 36 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2025

FIGURE 37 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)

FIGURE 38 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, CAGR (2026- 2033)

FIGURE 39 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 EUROPE POINT-OF-CARE-TESTING (POCT) MARKET: SNAPSHOT

FIGURE 41 EUROPE POINT-OF-CARE TESTING (POCT) MARKET: COMPANY SHARE 2025 (%)

Voir les informations détaillées

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

Questions fréquemment posées

Quels sont les principaux segments couverts dans le rapport Analyse de la taille, de la part et des tendances du marché ?

Le marché est segmenté en fonction de Marché européen des tests au point de service (POCT), par type de produit (produits de surveillance du glucose, produits de dépistage des maladies infectieuses, produits de surveillance cardiométabolique, produits de test de grossesse et de fertilité, produits de test d'hématologie, produits de surveillance de la coagulation, produits de test de drogues d'abus (DOA), produits de test d'analyse d'urine, produits de test de cholestérol, produits de test de marqueurs tumoraux/cancer, produits de test d'occultation fécale, et autres), par plateforme (tests de flux latéral/tests d'immunochromatographie, immuno-essais, bandelettes réactives, diagnostics moléculaires, tests de chimie clinique, microfluidique, hématologie, autres), par application (glycémie, maladies infectieuses, surveillance des signes vitaux, surveillance cardiaque, coagulation, hématologie, surveillance non invasive de la SpO2, transfusion sanguine, surveillance non invasive de la PCO2, analyse du sang total, Autres), par mode de prescription (tests sur ordonnance et tests en vente libre), par utilisateur final (hôpitaux, soins à domicile, cliniques, laboratoires, centres de diagnostic, laboratoires de pathologie, centres de chirurgie ambulatoire, centres de soins pour personnes âgées, autres), par canal de distribution (appel d'offres direct, ventes au détail, ventes en ligne et autres) - Tendances et prévisions du secteur jusqu'en 2032 .

Quelle est la taille actuelle du marché de Analyse de la taille, de la part et des tendances du marché ?

La taille du Analyse de la taille, de la part et des tendances du marché était estimée à 16.43 USD Billion USD en 2025.

Quel est le taux de croissance prévu du Analyse de la taille, de la part et des tendances du marché ?

Le Analyse de la taille, de la part et des tendances du marché devrait croître à un TCAC de 9.4% sur la période de prévision de 2026 à 2033.

Qui sont les principaux acteurs du Analyse de la taille, de la part et des tendances du marché ?

Les principaux acteurs du marché sont Abbott Point of Care Inc. ,Sinocare Inc. ,F. Hoffmann-La Roche Ltd ,Danaher Corporation ,Hologic Inc. ,bioMérieux SA.

Analyse de la taille, de la part et des tendances du marché des tests au point de service (POCT) en Europe : aperçu et prévisions du secteur jusqu'en 2032

Contournez les défis liés aux tarifs grâce à un conseil agile en chaîne d'approvisionnement

Europe Poct Market

TCAC : 9.40 %

Analyse du marché européen des tests au point de service (POCT)

Taille du marché européen des tests au point de service (POCT)

Analyse régionale du marché européen des tests au point de service (POCT)

Part de marché des tests au point de service (POCT) en Europe

Derniers développements sur le marché européen des tests au point de service (POCT)

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Table des matières

Liste des tableaux

Liste des figures

Méthodologie de recherche

Personnalisation disponible

Questions fréquemment posées

Rapports

Aperçus du marché

Soutien

Solutions

Analyse de la taille, de la part et des tendances du marché des tests au point de service (POCT) en Europe&nbsp;: aperçu et prévisions du secteur jusqu'en 2032

Contournez les défis liés aux tarifs grâce à un conseil agile en chaîne d'approvisionnement

Europe Poct Market

TCAC : 9.40 %

Analyse du marché européen des tests au point de service (POCT)

Taille du marché européen des tests au point de service (POCT)

Analyse régionale du marché européen des tests au point de service (POCT)

Part de marché des tests au point de service (POCT) en Europe

Derniers développements sur le marché européen des tests au point de service (POCT)

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

Table des matières

Liste des tableaux

Liste des figures

Méthodologie de recherche

Personnalisation disponible

Questions fréquemment posées

Parcourir les pages associées

Analyse de la taille, de la part et des tendances du marché des tests au point de service (POCT) en Europe : aperçu et prévisions du secteur jusqu'en 2032